carbapenems has been researched along with Thrombopenia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dissaneevate, S; Janjindamai, W; Maneenil, G; Phatigomet, M; Thatrimontrichai, A | 1 |
| Chen, M; Feng, N; Guo, W; Hu, J; Ju, M; Qian, Y; Yang, S | 1 |
| Chang, HT; Chang, SC; Chen, YC; Cheng, A; Chuang, YC; Sheng, WH; Sun, HY; Yang, CJ; Yang, JL | 1 |
3 other study(ies) available for carbapenems and Thrombopenia
| Article | Year |
|---|---|
Risk Factors for 30-Day Mortality in Neonates With Carbapenem-resistant A. baumannii Sepsis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Humans; Infant, Newborn; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors; Sepsis; Thrombocytopenia | 2022 |
Prevalence and risk factors for severe linezolid-associated thrombocytopenia in pediatric patients: An analysis of a public database.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Child; Humans; Linezolid; Piperacillin, Tazobactam Drug Combination; Platelet Count; Prevalence; Retrospective Studies; Risk Factors; Thrombocytopenia | 2023 |
Should we treat patients with only one set of positive blood cultures for extensively drug-resistant Acinetobacter baumannii the same as multiple sets?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenems; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Leukopenia; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Severity of Illness Index; Survival Analysis; Thrombocytopenia | 2017 |